Effect of high-dose statin versus low-dose statin plus ezetimibe on endothelial function: A meta-analysis of randomized trials

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 17, Issue 4, 2012, Pages 357-365

  Ye, Yicong ^a   Zhao, Xiliang ^a   Zhai, Guangyao ^a   Guo, Lilin ^a   Tian, Zhuang ^a   Zhang, Shuyang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

endothelial function; ezetimibe; statin

Indexed keywords

C REACTIVE PROTEIN; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; HUMAN; LOW DRUG DOSE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL, DIETARY; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; GASTROINTESTINAL AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INTESTINAL ABSORPTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASODILATION;

EID: 84866260952     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248412449384     Document Type: Article

References (43)

1. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001 ; 285 (19). 2486-2497
2. Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statin. Lancet. 2005 ; 366 (9493). 1267-1278
3. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010 ; 376 (9753). 1670-1681
4. Armitage J, Bowman L, et al. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. Lancet. 2010 ; 376 (9753). 1658-1669
5. Preiss D, Seshasai SR, Welsh P, et al. Risk of incident diabetes with intensive-dose compared with moderate- dose statin therapy: a meta-analysis. JAMA. 2011 ; 305 (24). 2556-2564
6. Ballantyne CM, Houri J, Notarbartolo A, et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation. 2003 ; 107 (19). 2409-2415
7. Kerzner B, Corbelli J, Sharp S, et al. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia. Am J Cardiol. 2003 ; 91 (4). 418-424
8. Tamaki N, Ueno H, Morinaga Y, Shiiya T, Nakazato M.. Ezetimibe ameliorates atherosclerotic and inflammatory markers, atherogenic lipid profiles, insulin sensitivity, and liver dysfunction in Japanese patients with hypercholesterolemia [published online ahead of a print February 22]. J Atheroscler Thromb. 2012 ;:
9. Turfaner N, Uzun H, Balci H, et al. Ezetimibe therapy and its influence on oxidative stress and fibrinolytic activity. South Med J. 2010 ; 103 (5). 428-433
10. Kastelein JJ, Akdim F, Stroes ES, et al. ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008 ; 358: 1431-1443
11. Rossebø AB, Pedersen TR, Boman K, et al. SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008 ; 359 (13). 1343-1356
12. Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011 ; 377 (9784). 2181-2192
13. Davignon J, Ganz P.. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004 ; 109:
14. Lerman A, Zeiher AM.. Endothelial function: cardiac events. Circulation. 2005 ; 111: 363-368
15. Blum A, Shamburek R. The pleiotropic effects of statin on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis. 2009 ; 203 (2). 325-330
16. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009 ; 151: 264-269
17. Deeks JJ, Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. Higgins JPT Green S., ed. Chichester, UK: John Wiley & Sons Ltd ; 2006: 269-270.
18. Kawagoe Y, Hattori Y, Nakano A, et al. Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients. Endocr J. 2011 ; 58 (3). 171-175
19. Araujo DB, Bertolami MC, Ferreira WP, et al. Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: comparative study between simvastatin and simvastatin/ezetimibe coadministration. J Cardiovasc Pharmacol. 2010 ; 55 (1). 1-5
20. Ostad MA, Eggeling S, Tschentscher P, et al. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study. Atherosclerosis. 2009 ; 205 (1). 227-232
21. Liu PY, Liu YW, Lin LJ, Chen JH, Liao JK. Evidence for statin pleiotropy in humans: differential effects of statin and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation. 2009 ; 119: 131-138
22. Olijhoek JK, Hajer GR, van der Graaf Y, Dallinga-Thie GM,, Visseren FL. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial. J Cardiovasc Pharmacol. 2008 ; 52 (2). 145-150
23. Settergren M, Böhm F, Rydén L, Pernow J. Cholesterol lowering is more important than pleiotropic effects of statin for endothelial function in patients with dysglycaemia and coronary artery disease. Eur Heart J. 2008 ; 29 (14). 1753-1760
24. Heitzer T, Baldus S, von Kodolitsch Y, Rudolph V,, Meinertz T. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. Arterioscler Thromb Vasc Biol. 2005 ; 25 (6). 1174-1179
25. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001 ; 104 (2). 191-196
26. Gokce N, Keaney JF, Hunter LM, Watkins MT,, Menzoian JO,, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation. 2002 ; 105 (13). 1567-1572
27. Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990 ; 86 (1). 228-234
28. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991 ; 338 (8782-8783). 1546-1550
29. Heitzer T, Ylä-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation. 1996 ; 93 (7). 1346-1353
30. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme: a reductase inhibitor, improves endothelial function within 1 month. Circulation. 1997 ; 95 (5). 1126-1131
31. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995 ; 332 (8). 481-487
32. Chen H, Ren JY, Xing Y, et al. Short-term withdrawal of simvastatin induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial nitric oxide synthase. Int J Cardiol. 2009 ; 131 (3). 313-320
33. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 1993 ; 341 (8859). 1496-1500
34. Tamai O, Matsuoka H, Itabe H, Wada Y,, Kohno K,, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 1997 ; 95 (1). 76-82
35. Fichtlscherer S, Schmidt-Lucke C, Bojunga S, et al. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy. Eur Heart J. 2006 ; 27 (10). 1182-1190
36. Mäki-Petäjä KM, Booth AD, Hall FC, et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol. 2007 ; 50 (9). 852-858
37. Gounari P, Tousoulis D, Antoniades C, et al. Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering. Int J Cardiol. 2010 ; 142 (1). 87-91
38. Ikeda N, Hara H, Suzuki M, et al. Impact of oxidized low density lipoprotein cholesterol under ezetimibe or rosuvastatin therapy on endothelial function. J Am Coll Cardiol. 2011 ; 57:
39. Balk EM, Lau J, Goudas LC, et al. Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review. Ann Intern Med. 2003 ; 139 (8). 670-682
40. Kinlay S. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis. J Am Coll Cardiol. 2007 ; 49 (20). 2003-2009
41. Berneis K, Rizzo M, Berthold HK, Spinas GA, Krone W, Gouni-Berthold I. Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial. Eur Heart J. 2010 ; 31 (13). 1633-1639
42. Geiss HC, Otto C, Parhofer KG. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins. Metabolism. 2006 ; 55 (5). 599-604
43. Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques. Clin Ther. 2007 ; 29 (11). 2419-2432